التقنية والذكاء الاصطناعي
FDA warns GLP-1 drugs may pose risk of rare condition that causes vision loss
المصدر: Ars Technica - All content · نُشر
The Food and Drug Administration is warning that popular obesity drugs—including Ozempic, Wegovy, Zepbound, and Mounjaro—may carry a "potential increased risk" of a rare eye condition that can lead to permanent vision loss. In a drug safety communication Monday , the FDA said it
The Food and Drug Administration is warning that popular obesity drugs—including Ozempic, Wegovy, Zepbound, and Mounjaro—may carry a "potential increased risk" of a rare eye condition that can lead to permanent vision loss. In a drug safety communication Monday , the FDA said it will now require makers of GLP-1 receptor agonist drugs to add a warning about that risk on their drug labels. The specific eye condition it warns of is called non-arteritic anterior ischemic optic neuropathy or NAION .
The condition is caused by restricted blood flow to the optic nerve, which leads to swelling and cell death and ultimately damages the nerve, causing abrupt vision loss that can often be permanent. It's unknown how GLP-1 drugs may cause NAION. The condition is rare overall, occurring in somewhere between two and 10 people in 100,000 in the general population, according to the American Academy of Ophthalmologists.
These small numbers have made it more difficult to determine with certainty if there is a connection. Further complicating the potential link is the fact that the risk factors for developing NAION are common among patients taking GLP-1 drugs. The risk factors include diabetes, cardiovascular disease, high blood pressure, high cholesterol, metabolic syndrome, and obstructive sleep apnea.
Read full article Comments
أخبار ذات صلة
Pharma firms’ focus on weight-loss drugs could put insulin supply at risk, experts warn
GLP-1 products such as Ozempic and Mounjaro spread but many in poorer countries struggle to get basic diabetes treatment The gold rush into GLP-1 weight-loss drugs risks diverting pharmaceutical firms’ attention away from diabetes treatments such as insulin, the head of the Acces
World news | The Guardian ·
Two mums take on a drugs company to fight for their children
Two mums tell their story of a scandal that led to 20,000 babies being born disabled.
feeds.bbci.co.uk ·
Scientists trick cancer cells into making the drugs that kill them
Scientists have developed a promising new cancer-fighting strategy that uses carbon monoxide naturally produced by tumor cells to manufacture powerful drugs inside the cancer cells themselves. Early laboratory experiments suggest the technique could selectively attack cancer whil
All Top News -- ScienceDaily ·
Ember’s latest self-heating 14-ounce mug is $50 off
You can toggle through temperature settings directly from the mug, or from within the app. | Image: The Verge If you were cool on the $149.95 original price of the 14-ounce Ember Mug 3 , you might warm up to the current discount happening at Amazon , Ember , and Best Buy for seve
The Verge ·
N-able takes its remote access service offline after researcher publishes dozens of zero-day bugs
The remote access giant also urged its self-hosted customers to take down their own servers amid a "critical security incident," fearing the possibility of cyberattacks.
TechCrunch ·